Conference
Abstract CT122: Randomized assessment of cisplatin dose interval for ototoxicity in the treatment of locally advanced squamous cell carcinoma of the head and neck undergoing curative concurrent chemoradiotherapy (RADIO)
Authors
Winquist E; Meyers B; Pond G; Hotte S; Black M; Parker C; Nichols A; Palma D; Kim R; Kuruvilla S
Pagination
pp. ct122-ct122
Publisher
American Association for Cancer Research (AACR)
Publication Date
July 1, 2019
DOI
10.1158/1538-7445.sabcs18-ct122
Name of conference
Clinical Trials